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Summary
Background and objective: Periodontal pathogen Porphyromonas gingivalis (P. gingivalis) increased car-
diomyocyte hypertrophy and apoptosis whereas Actinobaeillus actinomycetemcomitans and Prevotella
intermedia had no eﬀects. The purpose of this study is to clarify the role of calcineurin signaling pathway in
P. gingivalis-induced H9c2 myocardial cell hypertrophy and apoptosis. Methods: DNA fragmentation,
nuclear condensation, cellular morphology, calcineurin protein, Bcl2-associated death promoter (Bad) and
nuclear factor of activated T cell (NFAT)-3 protein products in cultured H9c2 myocardial cell were
measured by agarose gel electrophoresis, DAPI, immunoﬂuorescence, and Western blotting following
P. gingivalis and/or pre-administration of CsA (calcineurin inhibitors cyclosporin A). Results: P. gingivalis
not only increased calcineurin protein, NFAT-3 protein products and cellular hypertrophy, but also
increased DNA fragmentation, nuclear condensation and Bad protein products in H9c2 cells. The increased
cellular sizes, DNA fragmentation, nuclear condensation, and Bad of H9c2 cells treated with P. gingivalis
were all signiﬁcantly reduced after pre-administration of CsA. Conclusion: Our ﬁndings suggest that the
activity of calcineurin signal pathway may be initiated by P. gingivalis and further lead to cell hypertrophy
and death in culture H9c2 myocardial cells.
Introduction
The accumulation of epidemiologic, in vitro, ani-
mal and clinical evidence suggests that periodontal
infection may be a contributing risk factor for
heart diseases [1]. Periodontitis pathogens may
disseminate through the blood to infect the vas-
cular endothelium and contribute to the occur-
rence of atherosclerosis and risk of myocardial
ischemia and infarction [2]. Porphyromonas (P.)
gingivalis, a major pathogen of chronic adult
periodontitis, exhibits several potential virulence
properties which could play a role in the develop-
ment of cardiovascular disease as mediators of low
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density lipoprotein oxidation, foam cell formation,
and rupture of atherosclerotic plaque [3]. The
balance between cell death and cell survival is a
tightly controlled process, especially in terminally
diﬀerentiated cells, such as the cardiomyocyte [4].
Therefore, it becomes a very important issue
whether P. gingivalis will induce cardiomyocyte
apoptosis and hypertrophy. In our previous studies,
P. gingivalis increased cellular sizes, apoptosis, and the
activated apoptotic caspase-3, caspase-8, and cas-
pase-9 proteins of cardiomyocyte H9c2 cells
whereas Actinobaeillus actinomycetemcomitans and
Prevotella intermedia had no eﬀects. [5]. Besides,
P. gingivalis was demonstrated to adhere and to
invade aortic and heart endothelial cells [6]. How-
ever, the role of calcineurinmyocardial hypertrophy
and apoptosis induced by P. gingivalis is still
unclear.
Cardiac hypertrophy may initially be a beneﬁ-
cial adaptation that normalizes wall stress, but the
prolonged cardiac hypertrophy is a leading cause of
sudden death and heart failure [7]. Apoptosis had
been reported to contribute to the loss of myocar-
dial cells in cardiomyopathy, and is recognized as a
predictor of adverse outcomes in subjects with
cardiac diseases or heart failure [8]. Cardiac myo-
cyte apoptosis may occur in a variety of diseases,
such as hypertension, myocardial infarction, endo-
crine disorders, toxicants, and bacterial endocardi-
tis [9, 10]. Apoptosis is characterized by DNA-
fragmentation, nuclear condensation, and shifting
the balance between anti-apoptotic and pro-apop-
totic proteins towards the latter. [11]. Members of
the Bcl2 family are important regulators of pro-
grammed cell death and individual members that
can suppress (e.g. Bcl2) or promote (e.g. Bad)
apoptosis. The Bcl2-associated death promoter
(Bad), a pro-apoptotic member of the Bcl-2 family,
modulate death signaling and lead to release of
cytochrome c from the mitochondria into the
cytoplasm, which results in DNA fragmentation
and cell death by activation of caspase 9 and 3 [12].
Calcineurin is a calmodulin-dependent, serine/
threonine-speciﬁc phosphatase function within a
signal transduction pathway that regulates gene
expression and biological responses in many
important cell types [13]. Calcineurin was consid-
ered as an essential mediator of cardiac hypertro-
phy and apoptosis, and in most studies, calcineurin
inhibitors attenuated cardiac hypertrophy in vivo
and also attenuated apoptosis of cardiac myocytes
[14]. Calcineurin plays a critical role in the
apoptosis of cardiac myocytes through dephos-
phorylating Bad, thus enhancing Bad heterodi-
merization with Bcl-xL or other Bcl-2 family and
promoting apoptosis. [14, 15]. Calcineurin trans-
mits signals to the nucleus through the dephos-
phorylation and translocation of nuclear factor of
activated T cell (NFAT) transcription factors. [13,
16]. Calcineurin and its direct downstream tran-
scriptional eﬀector NFAT-3 potentially play a
regulatory role for maladaptive hypertrophy and
heart failure [16]. In human heart failure, the
calcineurin signaling pathway was activated not
only by an increased activity of calcineurin but
also by the shift from phosphorylated NFAT-3 to
the nucleus dephosphorylated NFAT-3 [17]. Once
activated, calcineurin will dephosphorylate NFAT-
3 and Bad, allowing translocation of these proteins
to the nucleus and mitochondria, respectively,
both of which may potentially lead to myocardial
pathologic hypertrophy and apoptosis [15]. How-
ever, it is unclear whether calcineurin signaling
pathways are involved in P. gingivalis-associated
myocardial cell hypertrophy and apoptosis.
The purpose of the current study is, ﬁrst to
determine the eﬀect of periodontal pathogen
P. gingivalis on calcineurin, Bad, and NFAT-3
protein levels, second to clarify whether P. gingi-
valis-induced H9c2 myocardial cell hypertrophy is
mediated via calcineurin signaling pathway, and
third to evaluate whether calcineurin/Bad signal-
ing pathways is related to P. gingivalis-induced
H9c2 myocardial cell apoptosis. We hypothesized
that calcineurin activity may be related to Por-




Porphyromonas (P.) gingivalis obtained from
American Type Culture Collection (ATCC
33277) was maintained on brain heart infusion
(BHI) enriched with Vitamin K3 (menadione,
0.5 mg/l) and hemin (5 mg/l) in an atmosphere
of 5% CO2, 10% H2, and 85% N2 at 37 C.
Turbidimetric method was used to evaluate bacte-
rial cultures with 2 McFarland standard (6108
colony forming units (CFUs)), the upper aqueous
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layer was collected following centrifugation at
10,000 g, ﬁltered through 0.22 lm ﬁlter, and
stored at )80 C. The upper aqueous layers of
P. gingivalis bacterial mediums were diluted to 10-
fold and 100-fold.
Cell culture
H9c2 cardiac cells were obtained from American
Type Culture Collection (ATCC CRL-1446) and
were cultured in Dulbecco’s modiﬁed essential
medium supplemented with 10% fetal bovine
serum, 2 mM glutamine, 100 units/ml penicillin,
100 lg/ml streptomycin, and 1 mM pyruvate in
humidiﬁed air (CO2 5%) at 37 C. H9c2 cells were
cultured in serum-free medium for 12 h, and then
treated with control (serum-free medium with
minimal essential medium) or CsA (0.5 lM/ml;
calcineurin inhibitors cyclosporin A) for 1 h and
post-treated with P. gingivalis bacterial 10-fold, or
100-fold diluted bacterial mediums. The incuba-
tion was continued for another 0.5, 1, 2 or 24 h,
and then the cells were harvested and extracted for
the analysis.
Actin-immunoﬂuorescence (rhodamine-phalloidin)
H9c2 cells were ﬁxed in fresh 3.7% paraformal-
dehyde and permeabilized with 2% Triton X-100
for 10 min, and blocked with PBS buﬀer with 1%
bovine serum albumin (PBS) for 15 min. Actin
ﬁlaments were stained by rhodamine-phalloidin.
Cells were examined and photographed using a
Zesis Axioskop and a confocal microscope. The
cell sizes were magniﬁed 100 times and analyzed
by digital image analysis, using Image-Pro Plus
software.
DNA fragmentation
H9c2 cells were lysed in 50 ll of lysis buﬀer
(50 mM Tris–HCl (pH 7.4), 20 mM EDTA, 1%
IGEPAL-630) followed by incubation with 1%
SDS and 5 lg/ ll RNase (Roche Molecular
Biochemicals, Mannheim, Germany) for 2 h at
56C and 2.5 g/ ll proteinase K (Roche) for 2 h at
37 C, and only fragmented DNA was extracted.
DNA was ethanol-precipitated and ﬁnally resus-
pended in distilled water. The fragmented DNA
was electrophoretically fractionated on 1.5% aga-
rose gel and stained with ethidium bromide.
Nuclear condensation stained with DAPI
H9c2 cells grown on 6 mm plate were washed
twice with PBS and ﬁxed for 30 min in 4%
buﬀered paraformaldehyde. The cells were then
stained with 1 lg/ml 4¢,6-diamidine-2-phenylin-
dole dihydrochloride (DAPI, Roche) for 30 min.
The stained cells were examined with ﬂuores-
cence microscopy. The nuclei condensation was
expressed by percentage (%) of cell death (nuclei
condensation) and expressed by relative percent-
age (%) of P. gingivalis induced cell death (nuclei
condensation).
Western blot analysis
Cultured H9c2 cells were scraped and washed once
with phosphate-buﬀered saline. Cell suspension
was then spun down, and cell pellets were lysed for
30 min in lysis buﬀer (50 mM Tris (pH 7.5), 0.5 M
NaCl, 1.0 mM EDTA (pH 7.5), 10% glycerol,
1 mM BME, 1% IGEPAL-630 and proteinase
inhibitor cocktail tablet (Roche)) and spun down
12,000 rpm for 10 min. Then, the supernatants
were applied to new eppendorf tube for Western
blot analysis. Proteins from H9c2 cell line was then
separated in 12% gradient SDS-PAGE and trans-
ferred to nitrocellulose membranes. Nonspeciﬁc
protein binding was blocked in blocking buﬀer
(5% milk, 20 mM Tris–HCl, pH 7.6, 150 mM
NaCl, and 0.1% Tween 20) and blotted with
speciﬁc antibodies of Bcl2-associated death pro-
moter (Bad), and NFAT-3 (Santa Cruz Biotech-
nology, Santa Cruz, CA, USA), and a-tubulin
(Neo Markers, Fremont, CA, USA) as indicated




To quickly assess whether calcineurin signaling
pathways were regulated by the periodontitis
pathogen P. gingivalis in myocardial cell, calci-
neurin total protein and its direct downstream
transcriptional eﬀector, NFAT-3, and Bad pro-
teins were measured by Western blotting in H9c2
cells cultured in serum-free medium (control) for
4 h or serum-free medium plus 10-fold diluted
(10 P. g) for 0.5 h (more details in Figure 1).
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Protocol 2
To assess whether calcineurin signaling pathways
mediate P. gingivalis-induced myocardial cell
hypertrophy, the cellular sizes were measured by
actin-immunoﬂuorescence in H9c2 myocardial
cells treated with either serum-free medium (con-
trol), or 10-fold diluted P. gingivalis for 24 h with
or without calcineurin inhibitors. Beside P. gingi-
valis induced calcineurin and NFAT-3 in H9c2 cells
were observed for 24 h (more details in Figure 2).
Protocol 3
To evaluate whether calcineurin is related to
P. gingivalis-induced Bcl2-associated death pro-
moter (Bad), the protein products of calcineurin
and Bad were measured by Western blotting
analysis in myocardial H9c2 cells with pre-
administration of serum-free medium (control) or
calcineurin inhibitors (CsA) for 1 h and with post-
administration of bacterial medium containing
10-fold diluted P. gingivalis medium for 0.5, 1,
and 2 h (more details in Figure 3).
Protocol 4
To assess whether calcineurin signaling pathways
mediate P. gingivalis induced myocardial cell
apoptosis, DNA fragmentations were measured
twice by agarose gel electrophoresis in H9c2
myocardial cells with pre-administration of ser-
um-free medium (control) or calcineurin inhibitors
(CsA) for 1 h and with post-administration of
bacterial medium containing 10-fold diluted
P. gingivalis medium for 24 h (more details in
Figure 4).
Protocol 5
To assess whether calcineurin signaling path-
ways mediate P. gingivalis induced myocardial cell
apoptosis, nuclei condensation was measured by
DAPI (4,6-diamidino-2-phenylindole) staining in
myocardial H9c2 cells with pre-administration of
serum-free medium (control) or calcineurin inhib-
itors (CsA) for 1 h and with post-administration of
bacterial medium containing 10-fold or 100-fold
diluted P. gingivalis medium for 24 h (more details
in Figure 5).
Statistics
The nuclei condensation and cellular size of
myocardial H9c2 cell were compared among
groups treated with either control, 10-fold diluted
P. gingivalis, and pre-treated calcineurin inhibitors
using one-way analysis of variance (ANOVA) with
pre-planned contrast comparison with control
group and 10-fold diluted P. gingivalis group. In
all cases, a diﬀerence at p<0.05 was considered
statistically signiﬁcant. All data presented in the
bar ﬁgures are means ±SD (n=6).
Results
Total calcineurin, activated Bad and NFAT-3
proteins were induced by P. gingivalis
Western blot analysis revealed that total calcineu-
rin, activated Bad and NFAT-3 proteins were
gradually increased in H9c2 cells after administra-
tion of 10-fold diluted P. gingivalis (10 P. g) for
0.5 h. compared with cultured in serum-free
medium (control) (Figure 1).
Figure 1. (a) The calcineurin, Bad, NFAT-3 protein products
were measured by Western Blotting in H9c2 cells cultured in
serum-free medium (control) for 4 h and then treated with or
without 10-fold diluted Porphyromonas gingivalis (10 P. g)
for 0.5 h. An internal control of a-tubulin was measured. (b)
Bars represent the relative densitometry analysis of calcineu-
rin/ a-tubulin, bad/ a- tubulin and NFAT-3/ a-tubulin to the
control levels and indicate mean values ± SD. (n=6)
*p<0.05,**p<0.01, signiﬁcant diﬀerent between P. gingivalis
and control.
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Calcineurin mediate P. gingivalis-induced
myocardial cell hypertrophy
P. gingivalis-induced total calcineurin and NFAT-3
were not only shown in early 0.5 h but was also
observed for 1, 2, 4, 8, 12, and 24 h (Figure
2a,2b). Actin-immunoﬂuorescence revealed that
the increased cellular sizes by 85% were ob-
served in myocardial H9c2 cells treated with 10-
fold diluted P. gingivalis medium for 24 h
compared with serum-free control (Figure 2c).
The P. gingivalis (10-fold diluted)-induced myo-
cardial cell hypertrophy were signiﬁcantly
reduced by pre-administration of CsA (calcineu-
rin inhibitor, 49% relative to cellular size of 10
P. g) (Figure 2d).
Figure 2. (a) Calcineurin and NFAT-3 protein products induced 10-fold diluted Porphyromonas gingivalis (10 P. g) for 24 h. (b)
Bars represent the relative densitometry analysis of calcineurin/ a-tubulin and NFAT-3/ a-tubulin to the control levels and indicate
mean values ± SD. (n=6) *p<0.05, signiﬁcant diﬀerent between P. gingivalis and control. (c) Cellular morphology was measured
by actin-immunoﬂuorescence in H9c2 myocardial cells treated with either control (Con, left panel), 10-fold diluted Porphyromonas
gingivalis medium only (10 P. g, middle panel), or pre-treated calcineurin inhibitors cyclosporin A (CsA, 10 lM/ml) for 1 h, and
then post-treated 10-fold diluted P. gingivalis medium for 24 h (10 P. g+ CsA, right panel) (d) Bars represent the relative cellular
sizes to control and indicate mean values ± SD. (n=6) ##p<0.01, signiﬁcant diﬀerent of cellular sizes between P. gingivalis and
control, **p<0.01, signiﬁcant diﬀerent of cellular areas between P. gingivalis and pre-treated signaling pathway inhibitors plus
P. gingivalis.
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Calcineurin mediate P. gingivalis induced Bad
measured by Western blotting
Western blot analysis revealed that mitochondrial
Bcl2-associated death promoter (Bad) protein
products were increased after administration of
10-fold diluted P. gingivalis (10 P. g) for 0.5, 1,
and 2 h (Figure 3). The increased activated Bad
protein induced by 10-fold diluted P. gingivalis in
H9c2 cell were signiﬁcantly reduced after pre-
administration of CsA (calcineurin inhibitor)
(Figure 3).
Calcineurin mediate P. gingivalis -induced
myocardial cell apoptosis measured by DNA
fragmentation
DNA ladder formation revealed that H9c2 myo-
cardial cell underwent DNA fragmentation and
apoptosis on exposure to either bacterial medium
containing 10-fold diluted P. gingivalis (10 P. g)
for 24 h compared to the serum free control
(Figure 4). The 10-fold diluted P. gingivalis in-
duced DNA fragmentation was attenuated by CsA
(calcineurin inhibitor).
Figure 3. (a) The represented protein products of mitochondrial Bcl2-associated death promoter (Bad) were measured by
Western Blotting in H9c2 cells cultured in serum-free medium (control) for 4 h or treated with 10-fold diluted P. gingivalis
(10 P. g) for 0.5 h, 1 h, and 2 h with or without pre-administration of calcineurin inhibitors cyclosporin A (CsA, 0.5
lM/ml) before 1 h. An internal control of a-tubulin was measured. (b) Bars represent the relative densitometry analysis of
Bad/ a-tubulin to the control level and indicate mean values ± SD. (n=6) #p<0.05,##p<0.01, signiﬁcant diﬀerent
between P. gingivalis and control, *p<0.05, **p<0.01, signiﬁcant diﬀerent between P. gingivalis and pre-treated CsA plus
P. gingivalis.
Figure 4. Represented DNA fragmentations were measured
by agarose gel electrophoresis in H9c2 myocardial cells. H9c2
cells were treated with either serum free for 4 h (control), pre-
treated with or without calcineurin inhibitors cyclosporin A
(CsA, 0.5 lM/ml) for 1 h, and then treated with bacterial
medium containing 10-fold diluted Porphyromonas gingivalis
(10 P. g) for 24 h.
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Calcineurin mediate P. gingivalis-induced
myocardial cell apoptosis measured by condensed
nuclei with DAPI staining
The condensation of nuclei stained with DAPI,
indicating cell apoptosis, was signiﬁcantly increased
after administration of 10-fold diluted P. gingivalis
for 24 h (10 P. g, p<0.01) and 100-fold diluted
P. gingivalis for 24 h (100 P. g, p<0.05) compared
with control (Con) (Figure 5). The 100-fold diluted
P. gingivalis-induced condensed nuclei in H9c2 cell
show no diﬀerences between with or without CsA
(calcineurin inhibitor), whereas the increased
condensed nuclei induced by 10-fold diluted
P. gingivalis were signiﬁcantly (p<0.01) reduced
after pre-administration of CsA.
Discussion
Major ﬁndings
Our main ﬁndings can be summarized as follows: (1)
Total calcineurin, activated Bad and NFAT-3 protein
in H9c2 cells were upregulated by P. gingivalis. (2)
P. gingivalis increased H9c2 cellular sizes, DNA
Figure 5. (a)Represented nuclei condensation expressed by % of cell death (nuclei condensation) was measured by DAPI (4,6-
diamidino-2-phenylindole) (1 lg/ml) staining in H9c2 myocardial cells treated with either control (Con, upper left panel), 10-fold
diluted Porphyromonas gingivalis medium (10X P. g, upper middle panel), pre-treated calcineurin inhibitors cyclosporin A (CsA;
0.5 lM/ml) plus post-treated 10-fold diluted bacterial medium (CsA +10 P. g, upper right panel), 100-fold diluted P. gingivalis
medium (100 P. g, lower left panel), pre-treated CsA plus post-treated 100-fold diluted P. gingivalis bacterial medium (CsA
+100 P. g, lower right panel) (b) Graphied by % of cell death. #p<0.05 # #p<0.01, signiﬁcant diﬀerent of % cell death (nuclei
condensation) between P. gingivalis and control, **p<0.01, signiﬁcant diﬀerent of % cell death (nuclei condensation) between P.
gingivalis and pre-treated calcineurin inhibitors plus P. gingivalis.
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fragmentation, and nuclear condensation in H9c2
myocardial cells, which imply P. gingivalis induced
myocardial cellular hypertrophy and apoptosis.
(3)The increases in cellular sizes, DNA fragmenta-
tion, nuclear condensation, and pro-apoptoric Bad
protein of H9c2 cells treated with P. gingivalis were
all reduced after pre-administration of CsA. In sum,
P. gingivalis-induced myocardial hypertrophy and
apoptosis appear to be mediated by calcineurin/
NFATor calcineurin/Bad signaling pathway.These
ﬁndings provide a potential link between P. gingi-
valis and calcineurin activity. After integrating
previous theories and our current ﬁndings into
one, we hypothesize that that myocardial cell
hypertrophy and myocardial cell apoptosis will be
induced by P. gingivalis via calcineurin/NFAT-3
pathway and calcineurin/Bad pathway, respectively
(shown in Figure 6).
Experimental limitation
P. gingivalis, a gram-negative anaerobe, is in-
volved in the pathogenesis of periodontal disease
and plays important roles in eliciting cellular
responses in various ways [18]. P. gingivalis pos-
sesses a variety of virulence factors including
gingipains, ﬁmbrillin peptides, capsule polysaccha-
rides, lipopolysaccharides, hemagglutinating and
hemolysing activities, toxic products of metabo-
lism, outer membrane vesicles, and other enzymes
[19]. Because of the widespread virulence factors,
P. gingivalis can produce myocardial cell apoptosis
via various virulence factors or metabolic byprod-
ucts. Therefore, we have to add a note of caution
that any eﬀect noted in the present investigation
cannot be isolated to any speciﬁc virulence factor
or any metabolic byproduct. Nevertheless, the goal
of the present study was to clarify the role of
calcineurin signaling pathway in P. gingivalis-
induced myocardial cell apoptosis. Clearly, addi-
tional experiments using a reductionist approach,
such as investigating gingipains alone or lipopoly-
saccharides alone, will be required in order to
identify which speciﬁc virulence factors or meta-
bolic byproducts directly cause myocardial cell
apoptosis.
P. gingivalis and cardiovascular system
Some studies indicated that P. gingivalis did aﬀect
the cardiovascular system, such as the coronary
arteries [3, 20]. P. gingivalis was suggested to
involve in atherosclerotic lesion formation [20] and
was found in the aorta of some cardiovascular
patients who had undergone open-heart surgery
[21], the latter of which suggests that periodontal
pathogen P. gingivalis did invade the cardiovascu-
lar system and might involve cardiovascular dis-
eases [21]. Most cross-sectional, prospective
epidemiological studies, animal model studies,
and cellular studies have demonstrated that peri-
odontal disease (P. gingivalis) may be associated
with endothelial cell, atherosclerosis formation,
and coronary heart disease [1–3, 6, 20, 21].
Myocardial ischemia and infarction are often
preceded by acute thromboembolic events induced
by periodontal disease, such as P. gingivalis [2]. In
our previous studies, P. gingivalis increased apop-
tosis and the activated apoptotic caspase-3, cas-
pase-8, and caspase-9 proteins of cardiomyocyte
H9c2 cells as well as P. gingivalis-induced apop-
totic activity of H9c2 cells were involved in p38,
ERK, PI3K, and calcineurin pathway, but might
play a protective role via JNK pathway [5]. In the
current study, we observed the two major calci-
neurin-mediated pathways in P. gingivalis-induced
myocardial cell hypertrophy and apoptosis.
P. gingivalis and calcineurin
Calcineurin, a Ca2+-calmodulin-dependent pro-
tein phosphatase is one of the links between Ca2+
signals and regulation of gene transcription in
cardiac muscle. Calcineurin has been implicated in
cardiovascular disease and is activated by numer-
ous stimuli, such as hypertension, ischemic/
Figure 6. After integrating previous theories and our current
ﬁndings into one, we hypothesized that myocardial cell hyper-
trophy and myocardial cell apoptosis may be induced by por-
phyromonas gingivalis via calcineurin/NFAT-3 pathway and
calcineurin/Bad pathway, respectively.
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re-perfusion, hypoxia, pressure-overload stress,
increase in cardiac pacing frequency [14, 22–24]
and periodontitis pathogens P. gingivalis found in
the current study. The current ﬁndings indicated
that P. gingivalis-induced H9c2 cell hypertrophy
and apoptosis was mediated by calcineurin signal-
ing pathways. Herein, our ﬁndings imply that
calcineurin signaling pathway in myocardial cell
can be activated by one more cellular stimulus,
P. gingivalis, i.e. periodontal infection. To our
knowledge, no other study looking into the direct
or indirect interaction between P. gingivalis and
calcineurin activity in all types of cells or systems.
This ﬁnding might provide a potential link
between P. gingivalis and calcineurin signaling
pathway. Therefore, more studies in the interac-
tion between P. gingivalis and calcineurin signaling
pathway in cardiovascular systems are needed.
Role of calcineurin in P. gingivalis-induced
myocardial cell hypertrophy
The heart is a dynamic organ capable of adapting
its size and architecture in response to various
stressors or bacterial infection [25, 26]. Our ﬁnd-
ings showed that myocardial cell sizes, total
calcineurin, and activated NFAT-3 were all in-
creased in H9c2 cells by 10-fold diluted P. gingi-
valis challenge and the increased myocardial cell
sizes-induced by P. gingivalis were reduced by
calcineurin inhibitor, suggesting that myocardial
cell hypertrophy will induced by P. gingivalis via
calcineurin/NFAT-3 pathway. The current ﬁnd-
ings provide a potential link between P. gingivalis
and calcineurin/NFAT-3 or calcineurin/Bad path-
way in myocardial cell hypertrophy or apopto-
sis. Calcineurin/NFAT was shown to induce
up-regulation of the Fas death apoptotic pathway
in neuronal cells [27]. Therefore, there is a limita-
tion in our study to clarify the relative role of
NFAT or Bad in hypertrophy or apoptosis.
Further studies are required to conﬁrm the role
of P. gingivalis on cardiac hypertrophy or heart
failure via calcineurin/NFAT-3 pathway.
Calcineurin role in P. gingivalis-induced myocardial
cell apoptosis
Apoptosis is characterized by DNA-fragmenta-
tion, nuclear condensation, and shifting the bal-
ance between anti-apoptotic and pro-apoptotic
proteins towards the latter [14, 15]. The mitochon-
drial Bcl2 family plays an important role in
cardiac apoptosis. Shifting the balance between
anti-apoptotic and pro-apoptotic Bcl2 family pro-
teins towards the latter (e.g. increased Bad pro-
teins) will cause releasing cytochrome c into
cytosol and activate caspase 9, which will activate
caspase 3 that is responsible for cleavage action
and DNA fragmentation. Our ﬁndings showed
that periodontal pathogen P. gingivalis increased
DNA fragmentation, nuclear condensation, and
activated Bad protein in H9c2 cells. All increases
were attenuated by calcineurin inhibitor, which
suggest that P. gingivalis induce H9c2 myocardial
cell apoptosis via calcineurin signaling pathway
and P. gingivalis-induced myocardial cell apopto-
sis may be involve in Bad related apoptotic
pathways.
Calcineurin plays a critical role in the pro-
apoptosis of cardiac myocytes through dephos-
phorylating pro-apoptotic protein Bad to promote
apoptosis. Our ﬁndings showed that the increased
Bad proteins induced by 0.5–2 h P. gingivalis
challenges were attenuated by calcineurin inhibi-
tors, which can be explained by the supposition
that calcineurin inhibitors may inhibit dephos-
phorylation of Bad and decrease activated Bad
protein level. Therefore, we can generally conclude
that calcineurin activity may be initiated by
P. gingivalis and may further activate Bad related
apoptotic pathways to lead cell death in culture
H9c2 myocardial cells. However, 100-fold diluted
P. gingivalis induced myocardial cell nuclear
condensation were not inhibited by CsA in the
current study. Therefore, we have to make a
cautious note that more diluted P. gingivalis-
induced myocardial cell apoptosis may not be
mediated via calcineurin signaling pathway.
Further hypotheses for clinical application
Our ﬁndings can provide a future hypothesis that
myocardial cell hypertrophy and apoptosis may
potentially gradually occur in patients with peri-
odontitis infected by P. gingivalis, which might be
mediated by calcineurin signaling pathways. In
order to prevent potential cardiac diseases, such as
pathologic cardiac hypertrophy or heart failure, in
periodontitis patients infected by P. gingivalis, the
infected patients have been suggested that they
should ideally maintain excellent oral hygiene
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and suppress P. gingivalis infection as much as
possible, and our ﬁndings further proposed that
calcineurin signaling pathways inhibitors may be a
good candidate for developing a future therapeutic
approach to prevent P. gingivalis-induced cardiac
hypertrophy and/or heart failure. Of course, fur-
ther clinical studies are needed to prove or
disprove our hypotheses for clinical application.
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